The specific inhibitors 1-naphthohydroxamic acid (Cpd2) and PCI-34051, for example, showed potential HDAC-8 inhibitory activity and thereby decreased the neuroblastoma cell viability [267]. The gene discussed is HDAC8; the disease is neuroblastoma.